Globus Medical, Inc.
GMED
$71.04
$1.361.95%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.52B | 2.48B | 2.24B | 1.90B | 1.57B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.52B | 2.48B | 2.24B | 1.90B | 1.57B |
| Cost of Revenue | 820.05M | 816.83M | 742.44M | 612.58M | 495.58M |
| Gross Profit | 1.70B | 1.66B | 1.49B | 1.29B | 1.07B |
| SG&A Expenses | 980.66M | 971.98M | 887.70M | 769.70M | 643.41M |
| Depreciation & Amortization | 119.37M | 117.58M | 101.27M | 76.11M | 51.03M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.08B | 2.09B | 1.91B | 1.62B | 1.31B |
| Operating Income | 436.18M | 390.19M | 328.60M | 279.87M | 254.44M |
| Income Before Tax | 120.72M | 121.05M | 66.55M | 93.65M | 165.39M |
| Income Tax Expenses | 17.74M | 29.54M | 25.88M | 27.02M | 42.52M |
| Earnings from Continuing Operations | 102.98 | 91.51 | 40.68 | 66.63 | 122.87 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 102.98M | 91.51M | 40.68M | 66.63M | 122.87M |
| EBIT | 436.18M | 390.19M | 328.60M | 279.87M | 254.44M |
| EBITDA | 690.20M | 647.15M | 556.00M | 461.76M | 399.17M |
| EPS Basic | 0.76 | 0.67 | 0.30 | 0.64 | 1.18 |
| Normalized Basic EPS | 1.80 | 1.82 | 1.55 | 1.50 | 1.59 |
| EPS Diluted | 0.75 | 0.66 | 0.29 | 0.63 | 1.16 |
| Normalized Diluted EPS | 1.77 | 1.80 | 1.53 | 1.48 | 1.57 |
| Average Basic Shares Outstanding | 542.90M | 544.05M | 521.97M | 487.15M | 452.07M |
| Average Diluted Shares Outstanding | 550.11M | 549.42M | 526.60M | 491.41M | 458.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
